PROlonGed ExpoSure Sertraline

Completed · Phase 4 · Has a placebo group

Conditions studied: Posttraumatic Stress Disorder

In brief

The current research study aims to compare the effectiveness of two proven treatments for posttraumatic stress disorder (PTSD): Prolonged Exposure (PE), sertraline, and their combination. In addition, the investigators are examining predictors of response to these two treatments and how PTSD symptoms, thoughts, and biological factors may be changed by such treatments. Biological mechanisms of change are also examined including emotion processing and regulation in fMRI, HPA axis function, and genetics and genomics. In addition, the investigators will examine acceptability of each treatment and reasons for ending treatment.

Key facts

Study ID
NCT01524133
Run by
VA Ann Arbor Healthcare System
People needed
223
Starts
2011-11-01
Expected to finish
2017-05-01
Last updated by the study team
2018-02-28

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.